We are live on ! Find out more
EFM

E Fund Management Portfolio holdings

AUM $3.37B
This Fund
S&P 500
This Quarter Est. Return
+12.44%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.31B
AUM Growth
+$49.5M
Cap. Flow
-$34.5M
Cap. Flow %
-2.63%
Top 10 Hldgs %
65.03%
Holding
329
New
20
Increased
146
Reduced
123
Closed
37

Top Buys

Rank Stock Value
1
KLAC icon
KLA
KLAC
+$10.2M
2
PDD icon
Pinduoduo
PDD
+$7.52M
3
RING icon
iShares MSCI Global Gold Miners ETF
RING
+$3.39M
4
IAU icon
iShares Gold Trust
IAU
+$3.38M
5
GLDM icon
SPDR Gold MiniShares Trust
GLDM
+$3.27M

Top Sells

Rank Stock Value
1
GRAB icon
Grab
GRAB
+$40.9M
2
NVDA icon
NVIDIA
NVDA
+$7.7M
3
MSFT icon
Microsoft
MSFT
+$6.02M
4
STAA icon
STAAR Surgical
STAA
+$5.62M
5
SE icon
Sea Limited
SE
+$3.76M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 45.37%
2 Technology 25.37%
3 Communication Services 8.93%
4 Healthcare 6.43%
5 Real Estate 6.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DXCM icon
126
DexCom
DXCM
$27.6B
$477K 0.04%
5,115
+819
+19% +$92.3K
HD icon
127
Home Depot
HD
$332B
$474K 0.04%
1,569
-123
-7% -$39.6K
NBIX icon
128
Neurocrine Biosciences
NBIX
$17.7B
$471K 0.04%
4,185
-598
-13% -$63K
ROP icon
129
Roper Technologies
ROP
$36.3B
$470K 0.04%
970
-76
-7% -$37.2K
CVX icon
130
Chevron
CVX
$388B
$467K 0.04%
2,769
-142
-5% -$22.9K
KDP icon
131
Keurig Dr Pepper
KDP
$40.4B
$466K 0.04%
14,752
+2,835
+24% +$93.5K
SRPT icon
132
Sarepta Therapeutics
SRPT
$1.66B
$462K 0.04%
3,814
+315
+9% +$35.6K
IMGN
133
DELISTED
Immunogen Inc
IMGN
$462K 0.04%
29,125
+10,992
+61% +$183K
UTHR icon
134
United Therapeutics
UTHR
$26.3B
$459K 0.03%
2,032
+77
+4% +$17.7K
BHVN icon
135
Biohaven
BHVN
$2.16B
$458K 0.03%
17,608
+7,415
+73% +$154K
HZNP
136
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$458K 0.03%
3,962
-539
-12% -$57.9K
APH icon
137
Amphenol
APH
$188B
$455K 0.03%
10,832
-798
-7% -$34.3K
HALO icon
138
Halozyme
HALO
$9.72B
$454K 0.03%
11,874
-1,278
-10% -$52.4K
EXEL icon
139
Exelixis
EXEL
$13.9B
$452K 0.03%
20,682
-2,581
-11% -$54K
PAYX icon
140
Paychex
PAYX
$40.4B
$450K 0.03%
3,903
+596
+18% +$71.8K
BMRN icon
141
BioMarin Pharmaceuticals
BMRN
$11.5B
$449K 0.03%
5,070
+181
+4% +$16.1K
CPRT icon
142
Copart
CPRT
$25.9B
$446K 0.03%
10,349
+1,783
+21% +$79.3K
ALKS icon
143
Alkermes
ALKS
$8.82B
$444K 0.03%
15,850
+1,502
+10% +$44K
TMO icon
144
Thermo Fisher Scientific
TMO
$211B
$444K 0.03%
876
+50
+6% +$26.6K
FOLD
145
DELISTED
Amicus Therapeutics
FOLD
$442K 0.03%
36,377
+1,510
+4% +$19.5K
SAGE
146
DELISTED
Sage Therapeutics
SAGE
$435K 0.03%
21,160
+13,703
+184% +$396K
RXRX icon
147
Recursion Pharmaceuticals
RXRX
$1.57B
$434K 0.03%
56,732
+39,503
+229% +$394K
IRWD icon
148
Ironwood Pharmaceuticals
IRWD
$611M
$432K 0.03%
44,896
+5,907
+15% +$57.9K
KHC icon
149
Kraft Heinz
KHC
$30.4B
$432K 0.03%
12,834
+2,311
+22% +$79.8K
BPMC
150
DELISTED
Blueprint Medicines
BPMC
$430K 0.03%
8,565
+926
+12% +$49.5K
4 5
6
7 8

Similar funds

VFCM
Valley Forge Capital Management Miami, Florida $3.38B AUM 15.93% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
DIA
Dana Investment Advisors Waukesha, Wisconsin $3.35B AUM 29.65% 1-Year Est. Return
5NCM
59 North Capital Management Houston, Texas $3.35B AUM 22.14% 1-Year Est. Return
TAM
Troy Asset Management London, United Kingdom $3.35B AUM 11.7% 1-Year Est. Return
CS
CapitalatWork SA Auderghem $3.35B AUM
OAM
Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return
QCG
Quadrant Capital Group Cincinnati, Ohio $3.34B AUM 29.16% 1-Year Est. Return

E Fund Management's Q3 2023 Portfolio in Review

As of Q3 2023, E Fund Management held 329 positions worth $1.31B, up 3.9% from $1.26B the previous quarter. Its ten largest holdings account for 65% of the portfolio.

E Fund Management's Q3 2023 filing shows 20 new, 146 increased, 123 reduced and 37 closed positions. Its largest new stake was iShares MSCI Global Gold Miners ETF: 148,564 shares worth $3.08M. The largest sale was Grab, an estimated $40.9M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 45% of assets, up from 37% a quarter earlier, followed by Technology and Communication Services.

  • E Fund Management's largest Q3 2023 buy was iShares MSCI Global Gold Miners ETF: 148,564 shares worth $3.08M.
  • E Fund Management added most to KLA in Q3 2023, an estimated $10.2M increase.
  • E Fund Management's biggest Q3 2023 reduction was NVIDIA, cutting an estimated $7.7M.
  • E Fund Management fully exited Grab in Q3 2023, selling an estimated $40.9M.
  • E Fund Management's ten largest holdings make up 65% of its $1.31B portfolio in Q3 2023.
  • E Fund Management opened 20 new positions and closed 37 in Q3 2023.
  • E Fund Management's portfolio value rose 3.9% quarter-over-quarter to $1.31B.

Based on E Fund Management's 13F filing for Q3 2023, filed 13 Nov 2023.